Resveratrol: A Double-Edged Sword in Health Benefits
Authors:
Top Cited Papers
Open Access
- 9 September 2018
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 6 (3) , 91
Abstract
Resveratrol (3,5,4′-trihydroxy-trans-stilbene) belongs to polyphenols’ stilbenoids group, possessing two phenol rings linked to each other by an ethylene bridge. This natural polyphenol has been detected in more than 70 plant species, especially in grapes’ skin and seeds, and was found in discrete amounts in red wines and various human foods. It is a phytoalexin that acts against pathogens, including bacteria and fungi. As a natural food ingredient, numerous studies have demonstrated that resveratrol possesses a very high antioxidant potential. Resveratrol also exhibit antitumor activity, and is considered a potential candidate for prevention and treatment of several types of cancer. Indeed, resveratrol anticancer properties have been confirmed by many in vitro and in vivo studies, which shows that resveratrol is able to inhibit all carcinogenesis stages (e.g., initiation, promotion and progression). Even more, other bioactive effects, namely as anti-inflammatory, anticarcinogenic, cardioprotective, vasorelaxant, phytoestrogenic and neuroprotective have also been reported. Nonetheless, resveratrol application is still being a major challenge for pharmaceutical industry, due to its poor solubility and bioavailability, as well as adverse effects. In this sense, this review summarized current data on resveratrol pharmacological effects.Keywords
This publication has 153 references indexed in Scilit:
- Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery DiseaseCardiovascular Drugs and Therapy, 2012
- The Anticancer Effects of Resveratrol: Modulation of Transcription FactorsNutrition and Cancer, 2012
- Trans-, cis-, and dihydro-resveratrol: a comparative studyBMC Chemistry, 2011
- Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor AxisCancer Research, 2010
- Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer PatientsCancer Research, 2010
- Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer StudyCancer Prevention Research, 2010
- Resveratrol as a Therapeutic Agent for Neurodegenerative DiseasesMolecular Neurobiology, 2010
- Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life SpanCell Metabolism, 2008
- Resveratrol directly targets COX‐2 to inhibit carcinogenesisMolecular Carcinogenesis, 2008
- Production of Resveratrol in Recombinant MicroorganismsApplied and Environmental Microbiology, 2006